Published in Lab Law Weekly, January 12th, 2007
A key bottleneck impeding the progress of the groundbreaking field of RNA interference (RNAi) has been the lack of effective delivery methods. This delivery breakthrough combined with RNAi creates a powerful discovery research tool for studying gene function in animal models, and in the long term might be used for certain human therapeutic tissues.
Hydrodynamic intravascular injection is a method to deliver nucleic acids...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.